COMBINATION OF NELFINAVIR, METFORMIN AND ROSUVASTATIN FOR TREATING CANCER CAUSED BY ABERRATIONS IN PTEN/TP53

• 收藏
• 分享

专利权人:

发明人:

Shireen Vali,Shahabuddin Usmani,Zeba Sultana,Ansu Kumar,Taher Abbasi,Robinson Vidva

申请号：

US15309144

公开号：

US20170056404A1

申请日:

2015.05.05

申请国别(地区):

US

年份:

2017

代理人:

摘要：

The present disclosure relates to a method of treating cancer using a composition comprising Nelfinavir, Metformin, Rosuvastatin, optionally along with a pharmaceutically acceptable excipient. The said composition is used for the treatment of cancer caused due to aberration in PTEN gene, optionally along with aberration in TP53 gene and related genes selected from group comprising PI3K, CDKN2A, MDM2 and MDM4.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/